Type II Kinase Inhibitors Targeting Cys-Gatekeeper Kinases Display Orthogonality With Wild Type and Ala/Gly-Gatekeeper Kinases

ACS Chemical Biology - United States
doi 10.1021/acschembio.8b00592
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)

Related search

Activation of Tyrosine Kinases by Mutation of the Gatekeeper Threonine

Nature Structural and Molecular Biology
Structural BiologyMolecular Biology
2008English

A Type-Ii Kinase Inhibitor Capable of Inhibiting the T315I “Gatekeeper” Mutant of BCR-Abl

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2010English

Allosterically Targeting EGFR Drug-Resistance Gatekeeper Mutations

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2017English

The Good (Gatekeeper), the Bad (Gatekeeper), and the Ugly (Situation)

Journal of General Internal Medicine
Internal Medicine
1999English

Pseudosubstrate Regulation of the Type II P21-Activated Kinases (PAKs)

Biophysical Journal
Biophysics
2013English

Phosphorylation of the Type 1A Angiotensin II Receptor by G Protein-Coupled Receptor Kinases and Protein Kinase C

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1996English

Targeting Protein Kinases for Bone Disease: Discovery and Development of SRC Inhibitors

2012English

Iso-Orthogonality and Type-Ii Duadic Constacyclic Codes

Finite Fields and Their Applications
Theoretical Computer ScienceApplied MathematicsNumber TheoryEngineeringAlgebra
2016English

Affinity-Based Probes Based on Type II Kinase Inhibitors

Journal of the American Chemical Society
BiochemistryColloidCatalysisChemistrySurface Chemistry
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy